Blog - Page 4178 of 5482

MondayNov 03, 2008 4:04 am

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a biopharmaceutical company, is focused on developing novel therapeutics based on RNA interference, or RNAi. By applying its therapeutic expertise in RNAi, the company intends to address substantial medical needs, many of which cannot be effectively addressed with small molecules or antibodies, the current major classes of drugs. Alnylam has taken a leadership role in the translation of RNAi as a new class of innovative medicines with peer-reviewed research efforts published in the world’s top scientific journals including Nature, Nature Medicine, and Cell. For further information, visit the Company's web site at www.alnylam.com.

MondayNov 03, 2008 4:04 am

Lorus Therapeutics, Inc. (AMEX: LRP)

Lorus Therapeutics, Inc. (AMEX: LRP), a biopharmaceutical company, is focused on discovering, researching and developing effective anticancer therapies with high safety profiles. By utilizing its own discovery efforts, in addition to acquisition and in-licensing programs, the company is building a portfolio of anticancer drugs ranging from discovery and preclinical to an advanced Phase II clinical trial. Each of the drug candidates in their current pipeline are backed by a strong intellectual property portfolio. For further information, visit the Company's web site at www.lorusthera.com.

MondayNov 03, 2008 4:03 am

LightPath Technologies, Inc. (NASDAQ: LPTH)

LightPath Technologies, Inc. (NASDAQ: LPTH) is a recognized leader in optical solutions for industrial, defense, communications, test and measurement, and medical applications. With unique products such as Black Diamond Infrared Lenses and Gradium Lenses, LightPath Technologies is shedding light in the field of optical solutions. For further information, visit the company website at: www.lightpath.com.

MondayNov 03, 2008 4:03 am

Allos Therapeutics, Inc. (NASDAQ: ALTH)

Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company, is committed to developing and commercializing innovative small molecule drugs for the treatment of cancer. Pralatrexate (PDX), the Company's lead product candidate, is a novel antifolate currently in a pivotal Phase 2 (PROPEL) trial. RH1, a targeted chemotherapeutic agent, is Allos Therapeutics’ other product candidate and is currently being evaluated in a Phase 1 trial. For further information, visit the Company's web site at www.allos.com.

MondayNov 03, 2008 4:03 am

LCA-Vision, Inc. (NASDAQ: LCAV)

LCA-Vision, Inc. (NASDAQ: LCAV) provides laser vision correction services under its well known Lasik Plus brand. The company currently owns and operates over 70 LasikPlus fixed-site laser vision correction centers in the United States and a joint venture in Canada. These laser correction centers are staffed with experienced ophthalmologists, optometrists and other healthcare professionals. To date, the company has performed more than a million vision correction procedures. For further information, visit the Company's web site at www.lcavision.com.

MondayNov 03, 2008 4:03 am

Alhambra Resources Ltd. (TSX: ALH CN)

Alhambra Resources Ltd. (TSX: ALH CN), a Canadian based exploration and gold production corporation, operates through its wholly owned subsidiary, Saga Creek Gold Corp LLP ("Saga Creek"). The company holds the rights to two Licenses that have an initial term of 25 years granted by the Republic of Kazakhstan in 1997. These two Licenses are the subject of an exploration and exploitation Contract between Saga Creek and the Republic of Kazakhstan, and will not expire until the year 2022. For further information, visit the Company's web site at www.alhambraresources.com.

MondayNov 03, 2008 4:02 am

LAURION Mineral Exploration Inc. (TSX: LME CN)

LAURION Mineral Exploration Inc. (TSX: LME CN), an exploration company, has its focus on discovering multiple, high-impact project, from gold projects to base metals and PGE’s. The company has key interests in highly prospective properties and aims to achieve long-term growth by making sound business decisions, creating strategic alliances with companies that have high technical expertise, and strategically target well positioned projects in geological systems where discoveries have been repetitive. For further information, visit the Company's web site at www.laurion.ca.

MondayNov 03, 2008 4:02 am

Alberta Oilsands Inc. (TSX: (OTC BB: AOS CN)

Alberta Oilsands Inc. (TSX: AOS CN), a junior oil sands development company, is focusing their operations on the Athabasca oil sands region of northeast Alberta. The company intends to create long term, sustainable value through the rapid delineation of the oil sands resources. Alberta’s strategy is to leverage its proven oil sands experience to delineate and prove up bitumen reserves sufficient to support a minimum 10,000 barrel per day in-situ project within five years. For further information, visit the Company's web site at www.aboilsands.ca.

MondayNov 03, 2008 4:01 am

Lake Shore Gold Corp. (TSX: LSG CN)

Lake Shore Gold Corp. (TSX: LSG CN), a mineral exploration company, is focused on rapidly moving towards production through a portfolio which includes an existing processing facility and a number of quality mineral properties located in the Timmins gold mining district of northern Ontario and Québec. In just the past year, Lake Shore Gold has completed a pre-feasibility study, identified a 1.2 million ounce ore reserve (uncut) and commenced an advanced exploration program at its 100%-owned Timmins West project. For further information, visit the Company's web site at www.lsgold.com

MondayNov 03, 2008 4:01 am

Labrador Iron Mines Holdings Limited (TSX: LIR CN)

Labrador Iron Mines Holdings Limited (TSX: LIR CN) has acquired interests in mineral claims and mineral licenses, through its wholly owned subsidiary, that contain an estimated 100 million tons of high grade iron ore. The company’s management team is comprised of experienced mining professionals, each of which has at least 30 years experience in the resource industry covering exploration, development, operations, company and project financing. For further information, visit the Company's web site at www.labradorironmines.ca.

Site Search

Company Search

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY)

Lorus Therapeutics, Inc. (AMEX: LRP)

LightPath Technologies, Inc. (NASDAQ: LPTH)

Allos Therapeutics, Inc. (NASDAQ: ALTH)

LCA-Vision, Inc. (NASDAQ: LCAV)

Alhambra Resources Ltd. (TSX: ALH CN)

LAURION Mineral Exploration Inc. (TSX: LME CN)

Alberta Oilsands Inc. (TSX: (OTC BB: AOS CN)

Lake Shore Gold Corp. (TSX: LSG CN)

Labrador Iron Mines Holdings Limited (TSX: LIR CN)

Market Basics

Newsletter Publishers

Public Companies